Final Analysis of a Randomized Phase 1b Trial to Assess Sequencing of the E39 and E39 ' Vaccines to Optimize Long-Term Antitumor Immunity in Folate Binding Protein (FBP) Expressing Tumors

Peace Kaitlin; Vreeland Timothy; Myers John W.; Ensley Daniel C.; Hale Diane F.; Jackson Doreen O.; Greene Julia M.; Clifton Guy T.; Peoples George E. Jr.; Mittendorf Elizabeth A.

首页> 外文期刊>Journal of the American College of Surgeons >Final Analysis of a Randomized Phase 1b Trial to Assess Sequencing of the E39 and E39 ' Vaccines to Optimize Long-Term Antitumor Immunity in Folate Binding Protein (FBP) Expressing Tumors

【24h】

Final Analysis of a Randomized Phase 1b Trial to Assess Sequencing of the E39 and E39 ' Vaccines to Optimize Long-Term Antitumor Immunity in Folate Binding Protein (FBP) Expressing Tumors

机译：对随机相1B试验的最终分析评估E39和E39'疫苗测序，优化表达肿瘤的叶酸结合蛋白（FBP）的长期抗肿瘤免疫力

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Journal of the American College of Surgeons》 |2017年第1期|共2页
作者
Peace Kaitlin; Vreeland Timothy; Myers John W.; Ensley Daniel C.; Hale Diane F.; Jackson Doreen O.; Greene Julia M.; Clifton Guy T.; Peoples George E. Jr.; Mittendorf Elizabeth A.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类外科学;
关键词

相似文献

外文文献
专利

1. Final Analysis of a Randomized Phase 1b Trial to Assess Sequencing of the E39 and E39 ' Vaccines to Optimize Long-Term Antitumor Immunity in Folate Binding Protein (FBP) Expressing Tumors [J] . Peace Kaitlin, Vreeland Timothy, Myers John W., Journal of the American College of Surgeons . 2017,第4Suppla1期

机译：对随机相1B试验的最终分析评估E39和E39'疫苗测序，优化表达肿瘤的叶酸结合蛋白（FBP）的长期抗肿瘤免疫力
2. Phase Ib trial of folate binding protein (FBP)-derived peptide vaccines, E39 and an attenuated version, E39 ': An analysis of safety and immune response [J] . Vreeland Timothy J., Litton Jennifer K., Qiao Na, Clinical immunology: The official journal of the Clinical Immunology Society . 2018,第期

机译：叶酸结合蛋白（FBP）的相位IB试验（FBP）的肽疫苗，E39和减毒版，E39'：安全性和免疫应答的分析
3. Phase Ib Trial Comparing Different Doses and Schedules of a Folate-Binding Protein-Derived Peptide Vaccine, E39, and its Attenuated Version, E39', to Induce Long-Term Folate-Binding Protein-Specific Immunity in Disease-Free Cancer Patients [J] . Jackson Doreen O., Vreeland Timothy, Hale Diane F., Journal of the American College of Surgeons . 2016,第4Suppla1期

机译：Ib期试验比较叶酸结合蛋白衍生的肽疫苗E39及其减毒版本E39'的不同剂量和时间表，以在无病癌症患者中诱导长期的叶酸结合蛋白特异性免疫。
4. Phase Ib Trial of Folate Binding Protein (FBP)-Derived Peptide Vaccines E39 and an Attenuated Version E39′: An Analysis of Safety and immune Response [O] . Timothy J. Vreeland, Jennifer K. Litton, Na Qiao, -1

机译：叶酸结合蛋白（FBP）衍生肽疫苗E39和减毒版E39的Ib期试验：安全性和免疫应答分析
5. Phase Ib trial of folate binding protein (FBP)-derived peptide vaccines, E39 and an attenuated version, E39’: An analysis of safety and immune response [O] . Timothy J. Vreeland, Jennifer K. Litton, Na Qiao, 2018

机译：叶酸结合蛋白（FBP）的相位IB试验（FBP）的肽疫苗，E39和减毒版，E39'：安全性和免疫应答的分析

Final Analysis of a Randomized Phase 1b Trial to Assess Sequencing of the E39 and E39 ' Vaccines to Optimize Long-Term Antitumor Immunity in Folate Binding Protein (FBP) Expressing Tumors

著录项

引文网络

相似文献

相关主题

期刊订阅